Researchers at Queen's University in Belfast have developed a new test that can radically improve the treatment of people with esophageal cancer.
Ireland has one of the highest rates of this form of cancer in Europe, with an average of 450 cases each year.
The new test developed by Queen's research team could change the decisions about which type of chemotherapy suits the early stages of cancer.
Dr. Richard Turkington, a senior clinical professor at Queens, says people who are diagnosed early are treated the same way today.
"At the moment, we have a one-size-fits-all approach where everyone gets the same chemotherapy and works better for some people than for others," Dr. Turkington explained.
"What our researchers have developed is a test to predict which patients should receive chemotherapy to truly match the right treatment for the right patients so that we can have a personalized approach and ensure that everyone has the best chance of getting the tumor. an operation. "